Ari Hirvonen
- Cancer Research top 0.5%
- Carcinogens and Genotoxicity Assessment 56
- Chemical Health and Safety top 0.5%
- Pharmacology top 0.2%
- Pharmacogenetics and Drug Metabolism 14
- Health, Toxicology and Mutagenesis top 0.5%
- Air Quality and Health Impacts 18
- Molecular Biology top 1%
- Glutathione Transferases and Polymorphisms 89
- Genomics, phytochemicals, and oxidative stress 39
- Epigenetics and DNA Methylation 23
- DNA Repair Mechanisms 13
-
- BRCA gene mutations in cancer 15
- Co-authors
- Hannu NorppaKirsti Husgafvel‐PursiainenHarri VainioSimone BenhamouKatja MitrunenPierre DayerDouglas A. BellSisko Anttila
- Journals
- SHILAP Revista de lepidopterología (2 papers)JNCI Journal of the National Cancer Institute (1 paper)Biochemical Journal (2 papers)
- Partner nations
- FinlandUnited StatesFrance
In The Last Decade
Ari Hirvonen
184 papers receiving 8.4k citations
Peers
Comparison fields: 5 of 172
- Cancer Research 2.7k
- Chemical Health and Safety 82
- Pharmacology 791
- Health, Toxicology and Mutagenesis 1.1k
- Molecular Biology 5.2k
Countries citing papers authored by Ari Hirvonen
This map shows the geographic impact of Ari Hirvonen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ari Hirvonen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ari Hirvonen more than expected).
Fields of papers citing papers by Ari Hirvonen
This network shows the impact of papers produced by Ari Hirvonen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ari Hirvonen. The network helps show where Ari Hirvonen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ari Hirvonen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 1 | |
| 2 | 2015 | 0 | |
| 3 | 2014 | 1 | |
| 4 | 2013 | 0 | |
| 5 | 2012 | 10 | |
| 6 | 2011 | 8 | |
| 7 | 2009 | 6 | |
| 8 | 2005 | 38 | |
| 9 | 2005 | 40 | |
| 10 | 2004 | 65 | |
| 11 | 2003 | 53 | |
| 12 | Point: myeloperoxidase -463G --> a polymorphism and lung cancer risk. | 2002 | 80 |
| 13 | 2002 | 47 | |
| 14 | 2001 | 89 | |
| 15 | Steroid metabolism gene CYP17 polymorphism and the development of breast cancer. | 2000 | 76 |
| 16 | 1999 | 82 | |
| 17 | 1999 | 69 | |
| 18 | 1993 | 44 | |
| 19 | 1989 | 25 | |
| 20 | 1988 | 3 |
About Ari Hirvonen
Ari Hirvonen is a scholar working on Cancer Research, Health, Toxicology and Mutagenesis and Molecular Biology, having authored 193 papers that have together received 8.8k indexed citations. Recurring topics across this work include Glutathione Transferases and Polymorphisms (89 papers), Carcinogens and Genotoxicity Assessment (56 papers), Genomics, phytochemicals, and oxidative stress (39 papers), Epigenetics and DNA Methylation (23 papers), Air Quality and Health Impacts (18 papers), BRCA gene mutations in cancer (15 papers), Pharmacogenetics and Drug Metabolism (14 papers) and DNA Repair Mechanisms (13 papers). The work is most often cited by research in Cancer Research (2.7k citations), Chemical Health and Safety (82 citations) and Pharmacology (791 citations). Ari Hirvonen has collaborated with scholars based in Finland, United States and France. Frequent co-authors include Hannu Norppa, Kirsti Husgafvel‐Pursiainen, Harri Vainio, Simone Benhamou, Katja Mitrunen, Pierre Dayer, Douglas A. Bell, Sisko Anttila, Christine Bouchardy and Daehee Kang. Their work appears in journals such as SHILAP Revista de lepidopterología, JNCI Journal of the National Cancer Institute and Biochemical Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.